Equillium
IPOPublic · San Diego, United States · Founded 2017
- Headquarters
- San Diego
- Founded
- 2017
- Business Model
- B2B
- Website
- equilliumbio.com
- Type
- Public
About
Equillium is a clinical-stage biotechnology company that leverages a deep understanding of immunobiology to develop novel therapeutics for severe autoimmune and inflammatory diseases with high unmet medical need. Headquartered in San Diego, its pipeline includes EQ504, a selective AhR modulator, and a proprietary multi-cytokine inhibitor platform of structured-domain peptides designed to selectively inhibit multiple disease-driving cytokines.
Summary
Equillium is a Biotech company based in San Diego, United States, founded in 2017.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2018
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...